Sufficient butyrate can prevent CRC by reducing oxidative damage to DNA, inducing apoptosis of DNA-damaged cells, inhibiting the growth of tumor cells, and reducing the activity of co-oncogenes [38,39]. Here, AQP1 is linked to neoplasm.